Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Nicholas Grund Resigns as Senior VP and Chief Commercial Officer at Akebia Therapeutics
Position
Chief Commercial Officer
Company
Akebia Therapeutics
Description
On October 7, 2026, Nicholas Grund announced his resignation as Senior Vice President and Chief Commercial Officer of Akebia Therapeutics, effective November 6, 2026. Following his departure, he will continue to provide consulting services to the company until April 30, 2027. This transition allows the company to retain his expertise during the adjustment period
Fundz sees it the moment Akebia Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Akebia Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.